Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report

…, A Ustianowski, E Elmahi, B Prudon, C Green, T Felton… - MedRxiv, 2020 - medrxiv.org
Background Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage.
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

…, J Lipman, JW Mouton, AA Vinks, TW Felton… - The Lancet infectious …, 2014 - thelancet.com
Infections in critically ill patients are associated with persistently poor clinical outcomes. These
patients have severely altered and variable antibiotic pharmacokinetics and are infected …

Tissue penetration of antifungal agents

T Felton, PF Troke, WW Hope - Clinical microbiology reviews, 2014 - Am Soc Microbiol
Understanding the tissue penetration of systemically administered antifungal agents is critical
for a proper appreciation of their antifungal efficacy in animals and humans. Both the time …

Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute …

…, K Ellis, S Farnell, H Farrah, E Fellows, T Felton… - Jama, 2021 - jamanetwork.com
Importance In patients who require mechanical ventilation for acute hypoxemic respiratory
failure, further reduction in tidal volumes, compared with conventional low tidal volume …

[PDF][PDF] Alterations in T and B cell function persist in convalescent COVID-19 patients

…, R Warren, T Williams, L Willmore, M Younas, T Felton… - Med, 2021 - cell.com
Background Emerging studies indicate that some coronavirus disease 2019 (COVID-19)
patients suffer from persistent symptoms, including breathlessness and chronic fatigue; however…

Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19

…, P Dark, GM Lord, A Simpson, T Felton… - Science …, 2020 - science.org
COVID-19 pathogenesis is associated with an exaggerated immune response. However,
the specific cellular mediators and inflammatory components driving diverse clinical disease …

Dexamethasone in hospitalized patients with Covid-19-preliminary report

…, E Elmahi, B Prudon, C Green, T Felton… - The New England …, 2020 - kclpure.kcl.ac.uk
Background: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage.
Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce …

[HTML][HTML] Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind …

…, J Engelbrecht, M Evans, T Farah, T Felton… - The Lancet Infectious …, 2022 - thelancet.com
Background Despite the availability of effective vaccines against COVID-19, booster
vaccinations are needed to maintain vaccine-induced protection against variant strains and …

Efficacy and safety of posaconazole for chronic pulmonary aspergillosis

TW Felton, C Baxter, CB Moore… - Clinical infectious …, 2010 - academic.oup.com
Background. Chronic pulmonary aspergillosis (CPA) is a severe, progressive respiratory
infection characterized by multiple pulmonary cavities and increased levels of antibodies to …

[HTML][HTML] ACCORD: a multicentre, seamless, phase 2 adaptive randomisation platform study to assess the efficacy and safety of multiple candidate agents for the …

…, M Carroll, G Griffiths, LP Ho, A De Soyza, T Felton… - Trials, 2020 - Springer
Objectives Stage 1: To evaluate the safety and efficacy of candidate agents as add-on therapies
to standard of care (SoC) in patients hospitalised with COVID-19 in a screening stage. …